Recently, patient groups have publicly requested AstraZeneca to disclose the patent rights issue of vaccine development , especially since the development is jointly funded by a large number of public funds in the United Kingdom and the United States. In response, AstraZeneca publicly stated that the currently signed cooperation agreement includes active cooperation with other suppliers to ensure that "all people around the world can have fair and equitable services." On May 29, the World Health Organization launched a new open voluntary registration mechanism for Covid-19 research and technology without patent rights, namely the
COVID-19 Technology whatsapp database Access Pool; in this way, patent rights can be assembled and trials managed. data and other shareable information. But interestingly, even under pressure from public spending on medicines, the UK government has not publicly expressed support or taken coercive measures . Global Justice Now and Just Treatment both stated that AstraZeneca's research and development of the vaccine comes from the NHS budget and from people's taxation. In addition to the UK's funds, it also includes the investment of US funds, that is, the company itself does not need to take great risks to develop and produce. Since it is a public resource,
Drug manufacturers must disclose the terms of patent licensing, and the government has a responsibility to prevent drug companies from taking advantage of relevant opportunities to monopolize profits under the budgetary pressure of the economic environment. Patent-free issues can only be requested with public funds, ensuring production and distribution to those who need it most . In addition, in addition to examining public-private partnerships and resolving the balance between public and private interests in vaccine research and development, humanitarian considerations are also the focus of attention.